Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

255 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
TP53 mutation, allelism and survival in non-small cell lung cancer.
Nelson HH, Wilkojmen M, Marsit CJ, Kelsey KT. Nelson HH, et al. Among authors: marsit cj. Carcinogenesis. 2005 Oct;26(10):1770-3. doi: 10.1093/carcin/bgi125. Epub 2005 May 19. Carcinogenesis. 2005. PMID: 15905205
Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival.
Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT. Marsit CJ, et al. Oncogene. 2004 Jan 29;23(4):1000-4. doi: 10.1038/sj.onc.1207256. Oncogene. 2004. PMID: 14647419
Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence.
Marsit CJ, Kim DH, Liu M, Hinds PW, Wiencke JK, Nelson HH, Kelsey KT. Marsit CJ, et al. Int J Cancer. 2005 Mar 20;114(2):219-23. doi: 10.1002/ijc.20714. Int J Cancer. 2005. PMID: 15540210
Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
Marsit CJ, Hasegawa M, Hirao T, Kim DH, Aldape K, Hinds PW, Wiencke JK, Nelson HH, Kelsey KT. Marsit CJ, et al. Cancer Res. 2004 Dec 1;64(23):8702-7. doi: 10.1158/0008-5472.CAN-04-2558. Cancer Res. 2004. PMID: 15574780
The race associated allele of Semaphorin 3B (SEMA3B) T415I and its role in lung cancer in African-Americans and Latino-Americans.
Marsit CJ, Wiencke JK, Liu M, Kelsey KT. Marsit CJ, et al. Carcinogenesis. 2005 Aug;26(8):1446-9. doi: 10.1093/carcin/bgi098. Epub 2005 Apr 14. Carcinogenesis. 2005. PMID: 15831529
Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A, Nelson HH, Kelsey KT. Marsit CJ, et al. Carcinogenesis. 2006 Jan;27(1):112-6. doi: 10.1093/carcin/bgi172. Epub 2005 Jun 29. Carcinogenesis. 2006. PMID: 15987713
Epigenetic silencing of the PRSS3 putative tumor suppressor gene in non-small cell lung cancer.
Marsit CJ, Okpukpara C, Danaee H, Kelsey KT. Marsit CJ, et al. Mol Carcinog. 2005 Oct;44(2):146-50. doi: 10.1002/mc.20125. Mol Carcinog. 2005. PMID: 16013053
PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration.
Marsit CJ, Zheng S, Aldape K, Hinds PW, Nelson HH, Wiencke JK, Kelsey KT. Marsit CJ, et al. Hum Pathol. 2005 Jul;36(7):768-76. doi: 10.1016/j.humpath.2005.05.006. Hum Pathol. 2005. PMID: 16084946
Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer.
Marsit CJ, Karagas MR, Andrew A, Liu M, Danaee H, Schned AR, Nelson HH, Kelsey KT. Marsit CJ, et al. Cancer Res. 2005 Aug 15;65(16):7081-5. doi: 10.1158/0008-5472.CAN-05-0267. Cancer Res. 2005. PMID: 16103055
Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer.
Hirao S, Hirao T, Marsit CJ, Hirao Y, Schned A, Devi-Ashok T, Nelson HH, Andrew A, Karagas MR, Kelsey KT. Hirao S, et al. Among authors: marsit cj. Cancer. 2005 Nov 1;104(9):1918-23. doi: 10.1002/cncr.21423. Cancer. 2005. PMID: 16149093
255 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback